CAL-MAINE FOODS INC (CALM)

US1280302027 - Common Stock

102.75  +2.16 (+2.15%)

After market: 102 -0.75 (-0.73%)

Fundamental Rating

7

Taking everything into account, CALM scores 7 out of 10 in our fundamental rating. CALM was compared to 91 industry peers in the Food Products industry. CALM has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CALM has a valuation in line with the averages, but it does not seem to be growing.



9

1. Profitability

1.1 Basic Checks

In the past year CALM was profitable.
CALM had a positive operating cash flow in the past year.
In the past 5 years CALM has always been profitable.
Each year in the past 5 years CALM had a positive operating cash flow.

1.2 Ratios

CALM's Return On Assets of 17.86% is amongst the best of the industry. CALM outperforms 97.80% of its industry peers.
The Return On Equity of CALM (22.44%) is better than 93.41% of its industry peers.
Looking at the Return On Invested Capital, with a value of 18.49%, CALM belongs to the top of the industry, outperforming 96.70% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CALM is significantly above the industry average of 8.80%.
Industry RankSector Rank
ROA 17.86%
ROE 22.44%
ROIC 18.49%
ROA(3y)20.27%
ROA(5y)12.5%
ROE(3y)24.83%
ROE(5y)15.31%
ROIC(3y)20.77%
ROIC(5y)N/A

1.3 Margins

CALM's Profit Margin of 16.09% is amongst the best of the industry. CALM outperforms 95.60% of its industry peers.
CALM's Profit Margin has improved in the last couple of years.
CALM has a better Operating Margin (18.87%) than 95.60% of its industry peers.
In the last couple of years the Operating Margin of CALM has grown nicely.
Looking at the Gross Margin, with a value of 28.01%, CALM is in the better half of the industry, outperforming 67.03% of the companies in the same industry.
In the last couple of years the Gross Margin of CALM has grown nicely.
Industry RankSector Rank
OM 18.87%
PM (TTM) 16.09%
GM 28.01%
OM growth 3YN/A
OM growth 5Y30.29%
PM growth 3Y324.94%
PM growth 5Y24.57%
GM growth 3Y24.03%
GM growth 5Y7.29%

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CALM is creating value.
The number of shares outstanding for CALM remains at a similar level compared to 1 year ago.
CALM has more shares outstanding than it did 5 years ago.
CALM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CALM has an Altman-Z score of 8.99. This indicates that CALM is financially healthy and has little risk of bankruptcy at the moment.
CALM's Altman-Z score of 8.99 is amongst the best of the industry. CALM outperforms 94.51% of its industry peers.
There is no outstanding debt for CALM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.99
ROIC/WACC2
WACC9.23%

2.3 Liquidity

CALM has a Current Ratio of 4.13. This indicates that CALM is financially healthy and has no problem in meeting its short term obligations.
CALM has a better Current ratio (4.13) than 93.41% of its industry peers.
CALM has a Quick Ratio of 3.23. This indicates that CALM is financially healthy and has no problem in meeting its short term obligations.
CALM has a better Quick ratio (3.23) than 94.51% of its industry peers.
Industry RankSector Rank
Current Ratio 4.13
Quick Ratio 3.23

3

3. Growth

3.1 Past

The earnings per share for CALM have decreased strongly by -37.60% in the last year.
Measured over the past years, CALM shows a very strong growth in Earnings Per Share. The EPS has been growing by 34.26% on average per year.
CALM shows a decrease in Revenue. In the last year, the revenue decreased by -9.98%.
CALM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.32% yearly.
EPS 1Y (TTM)-37.6%
EPS 3Y401.99%
EPS 5Y34.26%
EPS Q2Q%15200%
Revenue 1Y (TTM)-9.98%
Revenue growth 3Y19.92%
Revenue growth 5Y11.32%
Sales Q2Q%71.09%

3.2 Future

CALM is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -14.60% yearly.
CALM is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.80% yearly.
EPS Next Y72.75%
EPS Next 2Y-17.15%
EPS Next 3Y-14.6%
EPS Next 5YN/A
Revenue Next Year12.09%
Revenue Next 2Y-3.75%
Revenue Next 3Y-0.8%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.69, which indicates a correct valuation of CALM.
Compared to the rest of the industry, the Price/Earnings ratio of CALM indicates a rather cheap valuation: CALM is cheaper than 81.32% of the companies listed in the same industry.
CALM is valuated cheaply when we compare the Price/Earnings ratio to 27.54, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 29.58 indicates a quite expensive valuation of CALM.
The rest of the industry has a similar Price/Forward Earnings ratio as CALM.
CALM is valuated rather expensively when we compare the Price/Forward Earnings ratio to 23.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.69
Fwd PE 29.58

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CALM is valued cheaper than 86.81% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CALM indicates a somewhat cheap valuation: CALM is cheaper than 78.02% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.69
EV/EBITDA 5.52

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of CALM may justify a higher PE ratio.
A cheap valuation may be justified as CALM's earnings are expected to decrease with -14.60% in the coming years.
PEG (NY)0.17
PEG (5Y)0.37
EPS Next 2Y-17.15%
EPS Next 3Y-14.6%

6

5. Dividend

5.1 Amount

CALM has a Yearly Dividend Yield of 3.91%.
Compared to an average industry Dividend Yield of 3.82, CALM pays a better dividend. On top of this CALM pays more dividend than 85.71% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, CALM pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.91%

5.2 History

The dividend of CALM is nicely growing with an annual growth rate of 16.93%!
CALM has paid a dividend for at least 10 years, which is a reliable track record.
CALM has decreased its dividend in the last 3 years.
Dividend Growth(5Y)16.93%
Div Incr Years2
Div Non Decr Years2

5.3 Sustainability

CALM pays out 21.69% of its income as dividend. This is a sustainable payout ratio.
DP21.69%
EPS Next 2Y-17.15%
EPS Next 3Y-14.6%

CAL-MAINE FOODS INC

NASDAQ:CALM (12/24/2024, 7:59:58 PM)

After market: 102 -0.75 (-0.73%)

102.75

+2.16 (+2.15%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)10-01 2024-10-01/amc
Earnings (Next)12-30 2024-12-30/amc
Inst Owners90.32%
Inst Owner Change0.75%
Ins Owners1.29%
Ins Owner Change-0.09%
Market Cap4.55B
Analysts80
Price Target79.56 (-22.57%)
Short Float %7.29%
Short Ratio5.75
Dividend
Industry RankSector Rank
Dividend Yield 3.91%
Dividend Growth(5Y)16.93%
DP21.69%
Div Incr Years2
Div Non Decr Years2
Ex-Date10-30 2024-10-30 (1.02)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.76%
Min EPS beat(2)22.95%
Max EPS beat(2)28.57%
EPS beat(4)2
Avg EPS beat(4)-3.16%
Min EPS beat(4)-58.49%
Max EPS beat(4)28.57%
EPS beat(8)4
Avg EPS beat(8)-11.3%
EPS beat(12)5
Avg EPS beat(12)-14%
EPS beat(16)8
Avg EPS beat(16)25.38%
Revenue beat(2)2
Avg Revenue beat(2)14.27%
Min Revenue beat(2)3.21%
Max Revenue beat(2)25.32%
Revenue beat(4)2
Avg Revenue beat(4)6.43%
Min Revenue beat(4)-2.36%
Max Revenue beat(4)25.32%
Revenue beat(8)4
Avg Revenue beat(8)4.97%
Revenue beat(12)6
Avg Revenue beat(12)3.63%
Revenue beat(16)8
Avg Revenue beat(16)1.91%
PT rev (1m)0%
PT rev (3m)20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)428.49%
EPS NY rev (1m)2.21%
EPS NY rev (3m)45.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)42.96%
Revenue NY rev (1m)0%
Revenue NY rev (3m)13.11%
Valuation
Industry RankSector Rank
PE 12.69
Fwd PE 29.58
P/S 1.71
P/FCF 11.69
P/OCF 8.34
P/B 2.39
P/tB 2.47
EV/EBITDA 5.52
EPS(TTM)8.1
EY7.88%
EPS(NY)3.47
Fwd EY3.38%
FCF(TTM)8.79
FCFY8.56%
OCF(TTM)12.32
OCFY11.99%
SpS59.97
BVpS43.01
TBVpS41.6
PEG (NY)0.17
PEG (5Y)0.37
Profitability
Industry RankSector Rank
ROA 17.86%
ROE 22.44%
ROCE 24.24%
ROIC 18.49%
ROICexc 29.12%
ROICexgc 30.56%
OM 18.87%
PM (TTM) 16.09%
GM 28.01%
FCFM 14.66%
ROA(3y)20.27%
ROA(5y)12.5%
ROE(3y)24.83%
ROE(5y)15.31%
ROIC(3y)20.77%
ROIC(5y)N/A
ROICexc(3y)32.07%
ROICexc(5y)N/A
ROICexgc(3y)33.9%
ROICexgc(5y)N/A
ROCE(3y)27.23%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y33.01%
ROICexc growth 3YN/A
ROICexc growth 5Y33.69%
OM growth 3YN/A
OM growth 5Y30.29%
PM growth 3Y324.94%
PM growth 5Y24.57%
GM growth 3Y24.03%
GM growth 5Y7.29%
F-Score5
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 188.2%
Cap/Sales 5.89%
Interest Coverage 250
Cash Conversion 93.42%
Profit Quality 91.1%
Current Ratio 4.13
Quick Ratio 3.23
Altman-Z 8.99
F-Score5
WACC9.23%
ROIC/WACC2
Cap/Depr(3y)159.46%
Cap/Depr(5y)170.4%
Cap/Sales(3y)4.91%
Cap/Sales(5y)6.2%
Profit Quality(3y)81.96%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.6%
EPS 3Y401.99%
EPS 5Y34.26%
EPS Q2Q%15200%
EPS Next Y72.75%
EPS Next 2Y-17.15%
EPS Next 3Y-14.6%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.98%
Revenue growth 3Y19.92%
Revenue growth 5Y11.32%
Sales Q2Q%71.09%
Revenue Next Year12.09%
Revenue Next 2Y-3.75%
Revenue Next 3Y-0.8%
Revenue Next 5YN/A
EBIT growth 1Y-36.92%
EBIT growth 3YN/A
EBIT growth 5Y45.03%
EBIT Next Year109.53%
EBIT Next 3Y-5.88%
EBIT Next 5YN/A
FCF growth 1Y66.08%
FCF growth 3YN/A
FCF growth 5Y45.23%
OCF growth 1Y68.72%
OCF growth 3Y158.61%
OCF growth 5Y31.43%